Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver transplantation for malignancy.

Martin Hertl1, A Benedict Cosimi

  • 1Massachusetts General Hospital Transplant Unit, 55 Fruit Street, Blake 655, Boston, Massachusetts 02114, USA. mhertl@partners.org

The Oncologist
|April 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing Hope Through Science: The Inaugural Richard Slayman International Workshop on Xenotransplantation.

Transplantation·2026
Same author

Inactivating the Innate Immune Receptor CD11b With a First-in-class Monoclonal Antibody Prolongs the Survival of Kidney Allografts in Nonhuman Primates.

Transplantation·2025
Same author

Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease.

The New England journal of medicine·2025
Same author

Dysfunction of infiltrating cytotoxic CD8+ T cells within the graft promotes murine kidney allotransplant tolerance.

The Journal of clinical investigation·2024
Same author

Selective Bcl-2 inhibition promotes hematopoietic chimerism and allograft tolerance without myelosuppression in nonhuman primates.

Science translational medicine·2023
Same author

End-to-end anastomosis as a superior repair type to prevent recurrence of arteriovenous fistula aneurysms and improve patency outcomes.

The journal of vascular access·2022
Same journal

Target trial emulation studies in oncology: a comprehensive analysis.

The oncologist·2026
Same journal

Durable Response to Sotorasib in KRAS G12C-Mutant Intrahepatic Cholangiocarcinoma: A Case Report.

The oncologist·2026
Same journal

The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study.

The oncologist·2026
Same journal

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same journal

Molecular Tumor Board-Guided Osimertinib Therapy in EGFR L858R/Q701L-Mutant Lung Adenocarcinoma Supported by Functional Validation.

The oncologist·2026
Same journal

Phase 2 Dose Expansion Trial of OBI-3424, a DNA-Alkylating Prodrug, in Patients with Advanced Solid Tumors Expressing AKR1C3.

The oncologist·2026
See all related articles

Liver transplantation is a proven treatment for select hepatic malignancies. Careful patient selection is crucial for successful outcomes in hepatocellular cancer (HCC) and other liver tumors.

Area of Science:

  • Hepatobiliary Surgery
  • Transplantation Immunology
  • Surgical Oncology

Background:

  • Liver transplantation has evolved from a last resort to a standard treatment for specific liver cancers.
  • Initial outcomes highlighted the necessity of stringent patient selection criteria for optimal results.

Purpose of the Study:

  • To review the indications and outcomes of liver transplantation for various hepatic malignancies.
  • To identify patient subgroups that benefit most from liver transplantation for cancer treatment.

Main Methods:

  • Review of current literature and clinical practice regarding liver transplantation for hepatic malignancies.
  • Analysis of patient selection criteria, including tumor type, stage, and adjunctive therapies.

Main Results:

Related Experiment Videos

  • Hepatoblastoma in children and hepatocellular cancer (HCC) within Milan criteria in adults have good outcomes.
  • Epithelioid hemangioendothelioma and neuroendocrine liver metastases are indications; angiosarcoma and most metastatic disease are not.
  • Selected cases of cholangiocarcinoma may benefit from combined therapies including liver transplantation.

Conclusions:

  • Liver transplantation is a viable option for carefully selected patients with specific primary liver cancers and some metastatic tumors.
  • Further research is needed to establish criteria for selecting patients with extensive tumors for liver transplantation.